May 2020 FDA Recall Drug by West-ward Columbus Inc
D-1282-2020 - Failed Impurities/Degradation Specifications
This Class III drug recall was voluntarily initiated by West-ward Columbus Inc on May 13, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1282-2020
Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.
05-13-2020
05-27-2020
3336 Bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
West-Ward Columbus Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the US
10-02-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC: 0054-0415-25.
Batch or Lot Expiration Information
Lot# : AA4424A, Exp. 07/31/2020